Embecta closed its acquisition of Owen Mumford Holdings on Friday, shifting its focus from diabetes products to broader ...

On May 18, Bank of America analyst Travis Steed lowered the firm’s price target on Embecta Corp. (NASDAQ:EMBC) to $3 from $11 ...

Embecta's most recent quarterly report didn't give investors much to be exicited about.

Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter ...

There's been a major selloff in Embecta Corp. (NASDAQ:EMBC) shares in the week since it released its second-quarter report, with the stock down 61% to US$3.60. It was a pretty neg ...

The transaction supports Embecta’s plan to diversify by supplying drug delivery solutions to pharmaceutical partners.

Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global leader in diabetes care technology, today announced that it has completed its previously announced transaction to acquire Owen Mumford Holdings ...

View Embecta Corporation EMBC stock quote prices, financial information, real-time forecasts, and company news from CNN.

Becton, Dickinson and Co.’s board of directors approved the company’s diabetes spinoff, and set a date of April 1 for the move. The announcement of Embecta Corp.’s approval came Feb. 1, along with a ...

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company's recent U.S. business reset reflected a ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 6:00 PM EDTCompany ParticipantsDevdatt Kurdikar - President, CEO ...

The January ribbon cutting at embecta‘s new global headquarters in Parsippany was the latest step for one of the world’s largest pure-play diabetes management companies. “It was a really important ...